Kouo et al. also reported that in pancreatic cancer patients, the lower the number of lymphocytes surrounding tumor cells with high galectin-3 expression, the lower the patient survival and quality of life [110,111]. The gene discussed is LGALS3; the disease is familial pancreatic carcinoma.